Nodality scores $3.5M for personal diagnostics
Nodality, a biotech company that makes diagnostics focused on cell pathways, has brought in $3.5 million of an expected $10 million round of equity, according to a filing with the SEC. Based in South San Francisco, its backers include Kleiner Perkins Caufield & Byers, Maverick Capital and TPG Biotechnology.
Next Story: JukeFly re-launches personal online music player
Previous Story: Augmented reality company Layar gets $1M boost, launches on Symbian
Tags: co:Nodality, inv:Kleiner-Perkins-Caufield-&-Byers, inv:Maverick-Capital, inv:TPG-Biotechnology
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.